Crystalline ACAT inhibitor

Details for Australian Patent Application No. 2006217529 (hide)

International Classifications

Event Publications

19 July 2007 PCT application entered the National Phase

PCT publication WO2006/090274 Priority application(s): WO2006/090274

5 November 2009 Assignment before Grant

Warner-Lambert Company LLC The application has been assigned to Graceway Pharmaceuticals, LLC

17 May 2012 Application Accepted

Published as AU-B-2006217529

19 July 2012 Assignment before Grant

Graceway Pharmaceuticals, LLC The application has been assigned to Medicis Pharmaceutical Corporation

13 September 2012 Standard Patent Sealed

11 October 2012 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 31 Aug 2012 . Address for service in Australia - Allens Patent & Trade Mark Attorneys Level 28 Deutsche Bank Place Corner Hunter and Phillip Streets Sydney NSW 2000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.